{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T14:56:54Z","timestamp":1785423414216,"version":"3.56.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,7,7]],"date-time":"2022-07-07T00:00:00Z","timestamp":1657152000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,7,7]],"date-time":"2022-07-07T00:00:00Z","timestamp":1657152000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"publisher","award":["PR-R6-0113-11003"],"award-info":[{"award-number":["PR-R6-0113-11003"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"publisher","award":["PR-R6-0113-11003"],"award-info":[{"award-number":["PR-R6-0113-11003"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"publisher","award":["PR-R6-0113-11003"],"award-info":[{"award-number":["PR-R6-0113-11003"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"publisher","award":["PR-R6-0113-11003"],"award-info":[{"award-number":["PR-R6-0113-11003"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"publisher","award":["PR-R6-0113-11003"],"award-info":[{"award-number":["PR-R6-0113-11003"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"publisher","award":["PR-R6-0113-11003"],"award-info":[{"award-number":["PR-R6-0113-11003"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Lyme disease incidence is increasing in Europe, the USA, and Canada. In 2010, a comparison of surveillance systems for Lyme disease (LD) in humans in 28 European countries showed that systems highly varied, making epidemiological comparisons difficult. Details by country were not published. In 2018, one of LD clinical manifestations, neuroborreliosis, was added under European Union (EU) surveillance to standardise definitions. In this study, we identified and compared, 10\u00a0years after the European inventory, the characteristics of national surveillance systems and policies for LD in humans, with additional countries.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Thirty-four European and North American countries were included. Information on national \u201ctraditional\u201d systems (which compile data reported by clinicians and laboratories) and \u201cpublic participatory\u201d websites and mobile applications (which collect information directly from the public) were searched in MEDLINE, a systematic evidence map, and Google. An existing framework on LD surveillance was adapted to capture information on the administration level, indicators, reporting entities, coverage, and obligation to report.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>A surveillance system was found for 29 (85%) countries. Twenty-four had a traditional system alone, one had a public participatory system alone, and the remaining had both. Among countries with traditional systems, 23 (82%) administered them at the national level. Nineteen (68%) required mandatory reporting. Sixteen (57%) used both clinicians and laboratories as reporting entities. Eighteen (64%) employed case definitions, most of which considered both neuroborreliosis and erythema migrans (<jats:italic>n<\/jats:italic>\u2009=\u200914). Others monitored the number of positive laboratory tests and\/or patient consultations. Public participatory systems were only implemented in countries employing either also sentinels or voluntary surveys, or no traditional system, suggesting their use as a complementary tool. Only 56% of EU countries had neuroborreliosis as an indicator.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>The situation remains similar to 2010 with persisting heterogeneity between systems, suggesting that countries prioritise different surveillance objectives for LD. Without a common indicator in Europe, it is difficult to get a clear epidemiological picture. We discuss four factors that potentially influence LD surveillance strategies: perceptions of severity, burden on resources, two-way communication, and the medical conflicts about LD. Addressing these with countries might help moving towards the adoption of common practices.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12889-022-13669-w","type":"journal-article","created":{"date-parts":[[2022,7,7]],"date-time":"2022-07-07T13:06:28Z","timestamp":1657199188000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Comparison of national surveillance systems for Lyme disease in humans in Europe and North America: a policy review"],"prefix":"10.1186","volume":"22","author":[{"given":"Laurence","family":"Blanchard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Jones-Diette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theo","family":"Lorenc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katy","family":"Sutcliffe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Sowden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,7,7]]},"reference":[{"key":"13669_CR1","volume-title":"European Parliament resolution on Lyme disease (Borreliosis) (2018\/2774(RSP))","author":"European Parliament","year":"2018","unstructured":"European Parliament. European Parliament resolution on Lyme disease (Borreliosis) (2018\/2774(RSP)). 2018."},{"key":"13669_CR2","doi-asserted-by":"publisher","unstructured":"Schwartz AM, Hinckley AF, Mead PS, Hook SA, Kugeler KJ. Surveillance for Lyme Disease \u2014 United States, 2008\u20132015. MMWR Surveill Summ. 2017;66. https:\/\/doi.org\/10.15585\/mmwr.ss6622a1.","DOI":"10.15585\/mmwr.ss6622a1"},{"key":"13669_CR3","volume-title":"Stakeholder experiences of the diagnosis of Lyme disease: a systematic review","author":"G Brunton","year":"2017","unstructured":"Brunton G, Sutcliffe K, Hinds K, Khatwa M, Burchett H, Dickson K, et al. Stakeholder experiences of the diagnosis of Lyme disease: a systematic review. London: EPPI-Centre, Social Science Research Unit, UCL Institute of Education, University College London; 2017."},{"key":"13669_CR4","unstructured":"European Parliament. Commission implementing decision (EU) 2018\/945 of 22 June 2018 on the communicable diseases and related special health issues to be covered by epidemiological surveillance as well as relevant case definitions. Off J Eur Union. 2018;170:1-73."},{"key":"13669_CR5","volume-title":"Epidemiology of Lyme borreliosis and other tick-borne diseases in the Netherlands","author":"A Hofhuis","year":"2017","unstructured":"Hofhuis A. Epidemiology of Lyme borreliosis and other tick-borne diseases in the Netherlands. The Netherlands: Utrecht University; 2017."},{"key":"13669_CR6","doi-asserted-by":"publisher","unstructured":"van den Wijngaard CC, Hofhuis A, Sim\u00f5es M, Rood E, van Pelt W, Zeller H, et al. Surveillance perspective on Lyme borreliosis across the European Union and European Economic Area. Eurosurveillance. 2017;22. https:\/\/doi.org\/10.2807\/1560-7917.ES.2017.22.27.30569.","DOI":"10.2807\/1560-7917.ES.2017.22.27.30569"},{"key":"13669_CR7","doi-asserted-by":"publisher","DOI":"10.2196\/publichealth.7540","volume":"3","author":"MS Smolinski","year":"2017","unstructured":"Smolinski MS, Crawley AW, Olsen JM, Jayaraman T, Libel M. Participatory disease surveillance: engaging communities directly in reporting, monitoring, and responding to health threats. JMIR Public Health Surveill. 2017;3: e62. https:\/\/doi.org\/10.2196\/publichealth.7540.","journal-title":"JMIR Public Health Surveill"},{"key":"13669_CR8","unstructured":"European Centre for Disease Prevention and Control. Second expert consultation on tick-borne diseases with emphasis on Lyme borreliosis and tick-borne encephalitis. 22\u201323 November 2011. Stockholm, Sweden: European Centre for Disease Prevention and Control; 2012."},{"key":"13669_CR9","volume-title":"A systematic evidence map of research on Lyme disease in humans","author":"G Stokes","year":"2017","unstructured":"Stokes G, Blanchard L, Sutcliffe K, Dickson K, Brunton G, Burchett H, et al. A systematic evidence map of research on Lyme disease in humans. London: EPPI-Centre, Social Science Research Unit, UCL Institute of Education, University College London; 2017."},{"key":"13669_CR10","unstructured":"Bundesministerium f\u00fcr Gesundheit und Frauen [Austria]. Bundesgesetz zur \u00dcberwachung von Zoonosen und Zoonoseerregern (Zoonosengesetz), appendix I-B; 2021."},{"key":"13669_CR11","unstructured":"Sciensano [Belgium]. Sciensano & Lyme disease. 2018. https:\/\/www.sciensano.be\/en\/health-topics\/lyme-disease\/role . Accessed 13 Sept 2020."},{"key":"13669_CR12","volume-title":"Overview of communicable disease surveillance system in Bulgaria","author":"M Kojouharova","year":"2011","unstructured":"Kojouharova M. Overview of communicable disease surveillance system in Bulgaria. Sofia: Viral hepatitis prevention board meeting; 2011."},{"key":"13669_CR13","unstructured":"Hrvatski Sabor [Croatian Parliament]. Zakon o za\u0161titi pu\u010danstva od zaraznih bolesti 18.04.2020 [Law on Protection of the Population from Infectious Diseases 18.04.2020]. Zakon HR 2020. https:\/\/www.zakon.hr\/z\/1067\/Zakon-o-za%C5%A1titi-pu%C4%8Danstva-od-zaraznih-bolesti. Accessed 13 Sept 2020."},{"key":"13669_CR14","unstructured":"Ministerstva vnitra [Ministry of Interior of Czech Republic]. Vyhl\u00e1\u0161ka \u010d. 275 ze dne 13. z\u00e1\u0159\u00ed 2010, kterou se m\u011bn\u00ed vyhl\u00e1\u0161ka \u010d. 473\/2008 Sb., o syst\u00e9mu epidemiologick\u00e9 bd\u011blosti pro vybran\u00e9 infekce [Decree No. 275 of 13 September 2010 amending Decree No. 473\/2008 Coll., on the system of epidemiological vigilance for selected infections]. Sb Z\u00e1k \u010ces Repub 2010;103:4034\u201365."},{"key":"13669_CR15","unstructured":"Statens Serum Institut [Denmark]. Anmeldelse af sygdomme 2019. https:\/\/www.ssi.dk\/sygdomme-beredskab-og-forskning\/anmeldelse-af-sygdomme. Accessed 17 Dec 2020."},{"key":"13669_CR16","unstructured":"Tervise- ja t\u00f6\u00f6minister [Estonia]. Nakkushaiguste ja nakkushaiguskahtluse esinemise ning haigestumise ohutegurite ja ennetamise kohta teabe edastamise kord, nakkushaiguste loetelu ja andmesubjekti isikuandmetega edastatavate andmete koosseis, revision 28.11.2020 [Procedure for the transmission of information on the occurrence and suspicion of communicable diseases and communicable diseases, the list of communicable diseases and the composition of the data transmitted with the personal data of the data subject]. 2020."},{"key":"13669_CR17","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1186\/s12879-020-05555-w","volume":"20","author":"E Feuth","year":"2020","unstructured":"Feuth E, Virtanen M, Helve O, Hyt\u00f6nen J, Sane J. Lyme borreliosis in Finland: a register-based linkage study. BMC Infect Dis. 2020;20:819. https:\/\/doi.org\/10.1186\/s12879-020-05555-w.","journal-title":"BMC Infect Dis"},{"key":"13669_CR18","doi-asserted-by":"publisher","unstructured":"Septfons A, Goronflot T, Jaulhac B, Roussel V, De Martino S, Guerreiro S, et al. Epidemiology of Lyme borreliosis through two surveillance systems: the national Sentinelles GP network and the national hospital discharge database, France, 2005 to 2016. Eurosurveillance. 2019;24. https:\/\/doi.org\/10.2807\/1560-7917.ES.2019.24.11.1800134.","DOI":"10.2807\/1560-7917.ES.2019.24.11.1800134"},{"key":"13669_CR19","unstructured":"Centre national de r\u00e9f\u00e9rence des Borrelia [France]. Rapport annuel d\u2019activit\u00e9 2017. H\u00f4pitaux universitaires de Strasbourg; 2018."},{"key":"13669_CR20","doi-asserted-by":"publisher","first-page":"14976","DOI":"10.1038\/s41598-018-33136-0","volume":"8","author":"J Enkelmann","year":"2018","unstructured":"Enkelmann J, B\u00f6hmer M, Fingerle V, Siffczyk C, Werber D, Littmann M, et al. Incidence of notified Lyme borreliosis in Germany, 2013\u20132017. Sci Rep. 2018;8:14976. https:\/\/doi.org\/10.1038\/s41598-018-33136-0.","journal-title":"Sci Rep"},{"key":"13669_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.ttbdis.2020.101375","volume":"11","author":"D Zubrikov\u00e1","year":"2020","unstructured":"Zubrikov\u00e1 D, Wittmann M, H\u00f6nig V, \u0160vec P, V\u00edchov\u00e1 B, Essbauer S, et al. Prevalence of tick-borne encephalitis virus and Borrelia burgdorferi sensu lato in Ixodes ricinus ticks in Lower Bavaria and Upper Palatinate. Germany Ticks Tick-Borne Dis. 2020;11: 101375. https:\/\/doi.org\/10.1016\/j.ttbdis.2020.101375.","journal-title":"Germany Ticks Tick-Borne Dis"},{"key":"13669_CR22","unstructured":"Government of Hungary. 18\/1998. (VI. 3.) NM rendelet\u00a0: a fert\u0151z\u0151 betegs\u00e9gek \u00e9s a j\u00e1rv\u00e1nyok megel\u0151z\u00e9se \u00e9rdek\u00e9ben sz\u00fcks\u00e9ges j\u00e1rv\u00e1ny\u00fcgyi int\u00e9zked\u00e9sekr\u0151l [NM Regulation 18\/1998. (VI. 3.): epidemiological measures needed to prevent infectious diseases and epidemics] 2017. https:\/\/net.jogtar.hu\/jogszabaly?docid=99800018.nm. Accessed 28 Sept 2020."},{"key":"13669_CR23","unstructured":"Health Protection Surveillance Centre [Ireland]. Primary Prevention and Surveillance of Lyme Borreliosis in Ireland. Ireland: 2019."},{"key":"13669_CR24","unstructured":"Ministero della Salute [Italy]. Modalit\u00e0 di segnalazione delle malattie 2019. http:\/\/www.salute.gov.it\/portale\/malattieInfettive\/dettaglioContenutiMalattieInfettive.jsp?lingua=italiano&id=650&area=Malattie%20infettive&menu=sorveglianza. Accessed 6 Oct 2020."},{"key":"13669_CR25","unstructured":"Slim\u012bbu profilakses un kontroles centrs [Latvia]. Infekcijas slim\u012bbu re\u0123istr\u0101cija [Registration of infectious diseases] 2020. https:\/\/www.spkc.gov.lv\/lv\/infekcijas-slimibu-registracija. Accessed 7 Oct 2020."},{"key":"13669_CR26","unstructured":"Lietuvos respublikos sveikatos apsaugos ministras [Health Minister of the Republic of Lithuania]. \u012esakymas d\u0117l privalomojo epidemiologinio registravimo, privalomojo informacijos apie epidemiologinio registravimo objektus turinio ir informacijos privalomojo perdavimo tvarkos patvirtinimo, 2002 m. gruod\u017eio 24 d. Nr. 673 [Order regarding the approval of the procedure for the mandatory epidemiological registration, the procedure for the mandatory transmission of information on the content of information on the objects of epidemiological registration, 24 December 2002, no. 673] 2018. https:\/\/www.e-tar.lt\/portal\/lt\/legalAct\/TAR.733DC244327C\/zsczRicOEK. Accessed 10 Oct 2020."},{"key":"13669_CR27","unstructured":"Lietuvos respublikos sveikatos apsaugos ministro [Lithuania]. \u012esakymas d\u00e8l prane\u0161im\u0173 apie u\u017ekre\u010diam\u0105sias ligas ir j\u0173 suk\u00e8l\u00e8jus form\u0173 patvirtinimo 2009 m. gegu\u017e\u0117s 27 d. Nr. V-414 [Order Notification of communicable diseases and forms 27 May 2009 no. V-414]; 2019."},{"key":"13669_CR28","unstructured":"Gouvernement du Grand-Duch\u00e9 de Luxembourg. R\u00e8glement grand-ducal du 15 f\u00e9vrier 2019 portant \u00e9num\u00e9ration des maladies sujettes \u00e0 d\u00e9claration obligatoire et fixant les d\u00e9lais de d\u00e9claration ainsi que les informations \u00e0 reprendre au cahier des charges pour la d\u00e9signation comme laboratoire national de r\u00e9f\u00e9rence d\u2019un laboratoire d\u2019analyses m\u00e9dicales [Grand-Ducal Regulation of February 15, 2019 listing the diseases subject to mandatory notification and setting the reporting deadlines as well as the information to be included in the specifications for the designation as a national reference laboratory of a medical analysis laboratory] 2019. http:\/\/legilux.public.lu\/eli\/etat\/leg\/rgd\/2019\/02\/15\/a104\/jo. Accessed 11 Oct 2020."},{"key":"13669_CR29","unstructured":"Marsza\u0142ka Sejmu Rzeczypospolitej [Poland]. Ustawa z dnia 5 grudnia 2008 r. o zapobieganiu oraz zwalczaniu zaka\u017ce\u0144 i chor\u00f3b zaka\u017anych u ludzi [Ustawa z dnia 5 grudnia 2008 r. o zapobieganiu oraz zwalczaniu zaka\u017ce\u0144 i chor\u00f3b zaka\u017anych u ludzi]. Consolidated version as of 14\u201309\u20132020. Dz Ustaw. 2019;2."},{"key":"13669_CR30","unstructured":"Dire\u00e7\u00e3o-Geral da Sa\u00fade [Portugal]. Despacho n.o 12513-B\/2019 [Order No. 12513-B \/ 2019]. Di\u00e1rio Rep\u00fab 2a S\u00e9r 2019;251:331\u201325."},{"key":"13669_CR31","unstructured":"Institutul National de S\u0103n\u0103tate Republic\u00e2 Romania. Metodologia de supraveghere a Bolii Lyme [Lyme Disease Surveillance Methodology]. Institutul National de S\u0103n\u0103tate Republic\u00e2 Romania; 2020."},{"key":"13669_CR32","unstructured":"Slovenskej Republiky [Slovakia]. Z\u00e1kon \u010d. 355\/2007 Z. z. Z\u00e1kon o ochrane, podpore a rozvoji verejn\u00e9ho zdravia a o zmene a doplnen\u00ed niektor\u00fdch z\u00e1konov [Act no. 355\/2007 Coll. Act on the Protection, Promotion and Development of Public Health and on Amendments to Certain Acts], updated 10\/15\/2020. EpiSk 2020. https:\/\/www.epi.sk\/zz\/2007-355. Accessed 26 Oct 2020."},{"key":"13669_CR33","unstructured":"Republike Slovenije [Slovenia]. Pravilnik o spremembi in dopolnitvi Pravilnika o prijavi nalezljivih bolezni in posebnih ukrepih za njihovo prepre\u010devanje in obvladovanje [Rules amending and supplementing the Rules on the Application of Communicable Diseases and Specific Measures for Preventing and Controlling]. Pravno-Inf Sist. 2017. http:\/\/www.pisrs.si\/Pis.web\/pregledPredpisa?id=PRAV13203#. Accessed 25 Oct 2020."},{"key":"13669_CR34","unstructured":"Ministerio de ciencia e innovaci\u00f3n & Instituto de Salud Carlos III [Spain], Centro Nacional de Epidemiolog\u00eda [Spain]. Informe anual del sistema de informaci\u00f3n microbiol\u00f3gica 2017 [Annual report of the microbiological information system 2017]. Madrid: Instituto de Salud Carlos III; 2020."},{"key":"13669_CR35","unstructured":"Directorate of Health [Iceland]. Regulation on reporting of communicable diseases and agents posing a threat to public health, No. 221\/2012, as amended by Regulation No. 226\/2019."},{"key":"13669_CR36","doi-asserted-by":"publisher","unstructured":"MacDonald E, Vestrheim DF, White RA, Konsmo K, Lange H, Aase A, et al. Are the current notification criteria for Lyme borreliosis in Norway suitable? Results of an evaluation of Lyme borreliosis surveillance in Norway, 1995\u20132013. BMC Public Health. 2016;16. https:\/\/doi.org\/10.1186\/s12889-016-3346-9.","DOI":"10.1186\/s12889-016-3346-9"},{"key":"13669_CR37","unstructured":"Office f\u00e9d\u00e9ral de la sant\u00e9 publique [Switzerland]. Maladies transmises par les tiques \u2013 Situation en Suisse [Tick-borne diseases - Situation in Switzerland]. OFSP-Bull. 2020;20:7\u201310."},{"key":"13669_CR38","unstructured":"Public Health England [UK]. Zoonoses Report UK 2017. London: HM Government; 2018.\u00a0"},{"key":"13669_CR39","unstructured":"Public Health England [UK]. The Health Protection (Notification) Regulations 2010 No. 659."},{"key":"13669_CR40","unstructured":"Northern Ireland Parliament [UK]. Public Health Act (Northern Ireland) 1967."},{"key":"13669_CR41","unstructured":"Scotland Parliament [UK]. Public Health etc. (Scotland) Act 2008 asp 5."},{"key":"13669_CR42","unstructured":"Public Health Wales [UK]. 2010 No 1546 (W. 144) The Health Protection (Notification) (Wales) Regulations 2010."},{"key":"13669_CR43","unstructured":"Government of Canada. Surveillance of Lyme disease 2020. https:\/\/www.canada.ca\/en\/public-health\/services\/diseases\/lyme-disease\/surveillance-lyme-disease.html. Accessed 9 Nov 2020."},{"key":"13669_CR44","doi-asserted-by":"publisher","unstructured":"Lloyd VK, Hawkins RG. Under-Detection of Lyme Disease in Canada. Healthcare. 2018;6. https:\/\/doi.org\/10.3390\/healthcare6040125.","DOI":"10.3390\/healthcare6040125"},{"key":"13669_CR45","unstructured":"M\u0438\u043d\u0438c\u0442epc\u0442\u0432o\u0442o \u043da \u0437\u0434pa\u0432eo\u043fa\u0437\u0432a\u043de\u0442o [Ministry of Health of Bulgaria]. HAPE\u0414\u0411A \u2116 21 OT 18 \u042e\u041b\u0418 2005 \u0413. \u0417A PE\u0414A \u0417A PE\u0413\u0418CTPA\u0426\u0418\u042f, C\u042aO\u0411\u0429ABAHE \u0418 OT\u0427ET HA \u0417APA\u0417H\u0418TE \u0411O\u041bECT\u0418 [Ordinance of 21 July 2005 relating to the registration, communication and reporting of infectious diseases]. 2019."},{"key":"13669_CR46","unstructured":"Hrvatski Zavod Za Javno Zdravstvo [Croatia]. II. dio - Definicije za bolesti koje su odre\u0111ene Zakonom o za\u0161titi pu\u010danstva od zaraznih bolesti, a nisu me\u0111u bolestima koje je odredila Europska unija (I. dio definicija) [part II. Definitions for specified diseases under the Law on the Protection of the Population of infectious diseases, and that are not determined by the European Union (Part I definitions)]. Zagreb: 2020."},{"key":"13669_CR47","unstructured":"Minist\u00e8re de la sant\u00e9, Gouvernement du Grand-Duch\u00e9 de Luxembourg. D\u00e9claration des maladies infectieuses Lyme \/ Borr\u00e9liose (\u00e9ryth\u00e8mes migrants et formes neurologiques aigu\u00ebs) [ Declaration of Lyme \/ Borreliosis infectious diseases (erythema migrans and acute neurological forms)]. 2018."},{"key":"13669_CR48","unstructured":"Zak\u0142ad Epidemiologii chor\u00f3b zaka\u017anych I nadzoru [Poland]. Definicje przypadk\u00f3w chor\u00f3b zaka\u017anych na potrzeby nadzoru epidemiologicznego (67 definicji) [Definitions of infectious diseases for epidemiological surveillance (67 definitions)]. 2020."},{"key":"13669_CR49","unstructured":"Region\u00e1lny Urad Verejn\u00e9ho Zdravotn\u00edctva [Slovakia]. Anal\u00fdza epidemiologickej situ\u00e1cie a \u010dinnosti odborov epidemiol\u00f3gie v Slovenskej republike za rok 2019; 2019."},{"key":"13669_CR50","unstructured":"So\u010dan. Definicije prijavljivih nalezljivih bolezni za namene epidemiolo\u0161kega spremljanja [Definitions of infectious communicable diseases for epidemiological surveillance purposes]. Ljubljana, Slovenia: Nacionalni in\u0161titut za javno zdravje; 2020."},{"key":"13669_CR51","doi-asserted-by":"publisher","unstructured":"Vigf\u00fasson HB, Har\u00f0arson LS, L\u00fa\u00f0v\u00edksson BR, Gu\u00f0laugsson O. Lyme sj\u00fakd\u00f3mur \u00e1 \u00cdslandi \u2013 Faraldsfr\u00e6\u00f0i \u00e1 \u00e1runum 2011\u20132015 [Lyme disease in Iceland - Epidemiology in the years 2011\u20132015]. L\u00e6knabla\u00f0i\u00f0. 2019;105:63\u201370. https:\/\/doi.org\/10.17992\/lbl.2019.02.215.","DOI":"10.17992\/lbl.2019.02.215"},{"key":"13669_CR52","unstructured":"Government of Canada. National case definition: Lyme disease 2018. https:\/\/www.canada.ca\/en\/public-health\/services\/diseases\/lyme-disease\/health-professionals-lyme-disease\/national-case-definition.html. Accessed 8 Nov 2020."},{"key":"13669_CR53","unstructured":"Centers for Disease Control and Prevention [USA]. Lyme Disease (Borrelia burgdorferi): 2017 Case Definition. Natl Notif Dis Surveill Syst. 2017. https:\/\/wwwn.cdc.gov\/nndss\/conditions\/lyme-disease\/case-definition\/2017\/. Accessed 31 Oct 2020."},{"key":"13669_CR54","unstructured":"Ministerio de sanidad, servicios sociales e igualdad [Spain]. Orden SSI\/445\/2015, de 9 de marzo, por la que se modifican los anexos I, II y III del Real Decreto 2210\/1995, de 28 de diciembre, por el que se crea la Red Nacional de Vigilancia pidemiol\u00f3gica, relativos a la lista de enfermedades de declaraci\u00f3n obligatoria, modalidades de declaraci\u00f3n y enfermedades end\u00e9micas de \u00e1mbito regional. [Order SSI \/ 445\/2015, of March 9, which modifies Annexes I, II and III of Royal Decree 2210\/1995, of December 28, by which the Network is created National Epidemiological Surveillance, related to the list of diseases of mandatory declaration, declaration modalities and diseases endemics of regional scope.]. Bul Of Estado State Off Newsl. 2015;65:24012\u20135."},{"key":"13669_CR55","unstructured":"Robert Kock Institute [Germany]. Falldefinitionen \u00fcbertragbarer Krankheiten f\u00fcr den \u00d6GD. Epidemiologisches Bulletin. 2009;5."},{"key":"13669_CR56","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1111\/zph.12275","volume":"65","author":"HJ Rutz","year":"2018","unstructured":"Rutz HJ, Wee S, Feldman KA. Characterizing Lyme disease surveillance in an Endemic State. Zoonoses Public Health. 2018;65:247\u201353. https:\/\/doi.org\/10.1111\/zph.12275.","journal-title":"Zoonoses Public Health"},{"key":"13669_CR57","doi-asserted-by":"publisher","first-page":"242","DOI":"10.3201\/eid1802.101219","volume":"18","author":"S-H Ertel","year":"2012","unstructured":"Ertel S-H, Nelson RS, Cartter ML. Effect of surveillance method on reported characteristics of lyme disease, Connecticut, 1996\u20132007. Emerg Infect Dis. 2012;18:242\u20137. https:\/\/doi.org\/10.3201\/eid1802.101219.","journal-title":"Emerg Infect Dis"},{"key":"13669_CR58","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbspin.2021.105181","volume":"88","author":"G Coiffier","year":"2021","unstructured":"Coiffier G, Tattevin P. Lyme disease: \u201cEnd of the debate?\u201d Joint Bone Spine. 2021;88: 105181. https:\/\/doi.org\/10.1016\/j.jbspin.2021.105181.","journal-title":"Joint Bone Spine"},{"key":"13669_CR59","doi-asserted-by":"publisher","unstructured":"Antonise-Kamp L, Beaujean DJMA, Crutzen R, van Steenbergen JE, Ruwaard D. Prevention of tick bites: an evaluation of a smartphone app. BMC Infect Dis. 2017;17. https:\/\/doi.org\/10.1186\/s12879-017-2836-4.","DOI":"10.1186\/s12879-017-2836-4"},{"key":"13669_CR60","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1177\/1049732319846170","volume":"29","author":"K Hinds","year":"2019","unstructured":"Hinds K, Sutcliffe K. Heterodox and orthodox discourses in the case of lyme disease: a synthesis of arguments. Qual Health Res. 2019;29:1661\u201373. https:\/\/doi.org\/10.1177\/1049732319846170.","journal-title":"Qual Health Res"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-022-13669-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12889-022-13669-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-022-13669-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,7]],"date-time":"2022-07-07T13:08:34Z","timestamp":1657199314000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/s12889-022-13669-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,7]]},"references-count":60,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["13669"],"URL":"https:\/\/doi.org\/10.1186\/s12889-022-13669-w","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,7]]},"assertion":[{"value":"12 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable since this is an analysis of published information.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1307"}}